NCT01305239 A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients Status TERMINATED Phase N/A
NCT01303549 Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients Status COMPLETED Phase PHASE4
NCT01302262 Smoking-induced Dopamine Release: a [11C]-(+)-PHNO PET Study in Humans Status COMPLETED Phase N/A
NCT01302119 Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail Status COMPLETED Phase PHASE3
NCT01302067 A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine Status COMPLETED Phase PHASE4
NCT01302054 A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. Status COMPLETED Phase PHASE4
NCT01301508 Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01301456 Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females Status COMPLETED Phase PHASE1
NCT01300052 AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis Status COMPLETED Phase PHASE2
NCT01299480 A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years Status COMPLETED Phase PHASE2
NCT01299467 A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge Status WITHDRAWN Phase PHASE1
NCT01298544 A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers Status COMPLETED Phase PHASE4
NCT01298531 A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis Status COMPLETED Phase PHASE4
NCT01298518 A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients Status COMPLETED Phase PHASE1
NCT01298505 A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects Status TERMINATED Phase PHASE1
NCT01297595 Relative Bioavailability Of A Crizotinib Oral Liquid Formulation To Crizotinib Formulated Capsule Status COMPLETED Phase PHASE1
NCT01293825 Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad) Status COMPLETED Phase PHASE4